Sanofi-Regeneron’s Dupixent has been shown to relieve esophageal allergy symptoms in children







Newswires MT 2022

Analyst recommendations on SANOFI

2022 sales 41,632M
42,010M
42,010M
Net income 2022 7,936 million
8,008 million
8,008 million
Net debt 2022 7,873 million
7,945 million
7,945 million
PER 2022 ratio 15.1x
2022 return 3.57%
Capitalization 124B
125B
125B
EV / Sales 2022 3.17x
EV / Sales 2023 2.96x
# of employees 95,442
Floating 88.1%


Duration :

Period :




Sanofi Technical Analysis Chart |  MarketScreener

SANOFI Technical Analysis Trends

Short term Medium term Long term
Tendencies Neutral Neutral Bullish



Evolution of the income statement

Sale

To buy

Medium consensus SURPASS
Number of analysts 26
Last closing price €99.22
Average target price €114.41
Average Spread / Target 15.3%
1 Jan capi. ($M)
SANOFI 12.01% 125 195


Comments are closed.